NCT05299099

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

A Randomized, Open-label, Multi-center Phase III Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 in Postoperative Patients Requiring Central Parenteral Nutrition

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to evaluate the safety and efficacy of IN-C006 inj. and RCN301 in postoperative patients requiring central parenteral nutrition.

Detailed description

This study is a randomized, open-label, phase 3 design. The subject will be assigned to one of the two treatment groups (IN-C006 inj. or RCN301)

Conditions

• Parenteral Nutrition

Interventions

Type	Name	Description
DRUG	IN-C006 inj.	IN-C006 will be injected continuously for 3 days.
DRUG	RCN301	RCN301 will be injected continuously for 3 days.

Timeline

• Start date: 2022-05-04
• Primary completion: 2022-12-09
• Completion: 2022-12-15
• First posted: 2022-03-28
• Last updated: 2023-09-28

Locations

1 site across 1 country: South Korea